Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Localized Prostate Cancer × Tablets × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 3 Urinary Bladder Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Localized Prostate Cancer 1 Insulin Resistance 1 Head and Neck Neoplasms 1 Erectile Dysfunction 1 Carcinoma, Renal Cell 1 Adenocarcinoma of Lung 1

Interventions

padeliporfin 1 Tablets 1 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06966778 2026-03-16

Oxybutynin ER to Promote Early Continence Recovery After Robotic Prostatectomy: A Randomized Controlled Trial

National Taiwan University Hospital

Phase NA Recruiting

Localized Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡